• Loading stock data...
Est. 2004

Sunday 02/17/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More


  • 3:42 PM

    Research Article Describes Inadequate Funding Levels for Vaccines Against HIV, Malaria and Tuberculosis ATLANTA, GA, Sept. 19, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today commented on a research article describing a study funded by the Gates Foundation.  In the article, “Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model”, published at Gates Open Research1, the authors discussed their review of product development pipelines for 35

    Read more
  • 4:10 PM

    ATLANTA, GA–(Marketwired – Nov 7, 2016) – GeoVax Labs, Inc. (OTCQB: GOVX) announced today its collaboration with ViaMune, Inc. for the co-development of each company’s cancer immunotherapy programs. Both companies’ products target an abnormal form of the autologous cell surface-associated protein, Mucin 1 (MUC1), which is over-expressed in the majority of known tumor types. Due to overexpression and/or aberrant glycosylation of MUC1, this “tumor-associated antigen” (TAA) is often recognized as abnormal by patients’ immune system but is not sufficiently immunogenic

    Read more
  • 1:44 PM

    Supports Development of a Vaccine to Prevent Clade C HIV Prevalent in the Developing World ATLANTA, GA–GOVX, (Marketwired – Jun 29, 2016) – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in the development of human vaccines, announced today it has received a Notice of Award from the U.S. National Institutes of Health (NIH) for a Small Business Innovative Research (SBIR) grant in support of its clade C HIV vaccine development program for Africa. The grant award of $294,038

    Read more
  • 7:23 PM

      MARLBORO, May 07, 2014 (GLOBE NEWSWIRE via COMTEX) — U.S. Precious Metals, Inc. (“Company”) (OTCQB:USPR) is pleased to announce that on May 10, 2014, Mesa Acquisition Group, LLC, our Joint Venture partner, will begin the ground work phase of identifying mineralization on the approximately 2,000 acres of its 37,000 acre concession. This phase will take approximately 12 days to complete and results are expected within 45-60 days following completion. This phase is a follow up to the satellite imaging

    Read more
Public Wire Banner